2024 Q2 Form 10-Q Financial Statement
#000148500324000009 Filed on May 09, 2024
Income Statement
Concept | 2024 Q2 | 2024 Q1 |
---|---|---|
Revenue | $9.200M | $3.400M |
YoY Change | 155.56% | 4.84% |
Cost Of Revenue | ||
YoY Change | ||
Gross Profit | ||
YoY Change | ||
Gross Profit Margin | ||
Selling, General & Admin | $5.560M | $5.445M |
YoY Change | -7.49% | -43.1% |
% of Gross Profit | ||
Research & Development | $15.31M | $17.46M |
YoY Change | -17.34% | 4.93% |
% of Gross Profit | ||
Depreciation & Amortization | $255.0K | $1.693M |
YoY Change | -64.08% | 138.45% |
% of Gross Profit | ||
Operating Expenses | $20.87M | $22.91M |
YoY Change | -14.92% | -12.62% |
Operating Profit | -$11.67M | -$19.51M |
YoY Change | -44.34% | -15.07% |
Interest Expense | $508.0K | $532.0K |
YoY Change | -56.84% | -136.02% |
% of Operating Profit | ||
Other Income/Expense, Net | ||
YoY Change | ||
Pretax Income | -$11.16M | -$18.98M |
YoY Change | -43.6% | -22.63% |
Income Tax | $0.00 | $0.00 |
% Of Pretax Income | ||
Net Earnings | -$11.16M | -$18.98M |
YoY Change | -43.84% | -22.99% |
Net Earnings / Revenue | -121.33% | -558.18% |
Basic Earnings Per Share | -$0.27 | -$0.46 |
Diluted Earnings Per Share | -$0.27 | -$0.46 |
COMMON SHARES | ||
Basic Shares Outstanding | 41.54M shares | 41.54M shares |
Diluted Shares Outstanding | 41.54M shares | 40.94M shares |
Balance Sheet
Concept | 2024 Q2 | 2024 Q1 |
---|---|---|
SHORT-TERM ASSETS | ||
Cash & Short-Term Investments | $40.36M | $56.52M |
YoY Change | -65.53% | -59.34% |
Cash & Equivalents | $40.36M | $56.52M |
Short-Term Investments | ||
Other Short-Term Assets | $8.359M | $4.438M |
YoY Change | 63.9% | -19.31% |
Inventory | ||
Prepaid Expenses | ||
Receivables | ||
Other Receivables | ||
Total Short-Term Assets | $50.72M | $60.95M |
YoY Change | -58.49% | -57.82% |
LONG-TERM ASSETS | ||
Property, Plant & Equipment | $8.476M | $12.70M |
YoY Change | 11.67% | 56.65% |
Goodwill | ||
YoY Change | ||
Intangibles | ||
YoY Change | ||
Long-Term Investments | ||
YoY Change | ||
Other Assets | $142.0K | $142.0K |
YoY Change | -29.0% | |
Total Long-Term Assets | $8.618M | $12.84M |
YoY Change | -20.3% | 10.42% |
TOTAL ASSETS | ||
Total Short-Term Assets | $50.72M | $60.95M |
Total Long-Term Assets | $8.618M | $12.84M |
Total Assets | $59.34M | $73.80M |
YoY Change | -55.39% | -52.74% |
SHORT-TERM LIABILITIES | ||
YoY Change | ||
Accounts Payable | $2.033M | $2.166M |
YoY Change | -18.25% | -53.06% |
Accrued Expenses | $9.241M | $4.729M |
YoY Change | -3.88% | -53.58% |
Deferred Revenue | ||
YoY Change | ||
Short-Term Debt | $0.00 | $0.00 |
YoY Change | ||
Long-Term Debt Due | $1.283M | $1.390M |
YoY Change | 6.92% | 15.83% |
Total Short-Term Liabilities | $15.62M | $13.14M |
YoY Change | -13.11% | -38.81% |
LONG-TERM LIABILITIES | ||
Long-Term Debt | $502.0K | $869.0K |
YoY Change | -16.33% | 24.14% |
Other Long-Term Liabilities | $815.0K | $1.131M |
YoY Change | -54.95% | -40.38% |
Total Long-Term Liabilities | $815.0K | $1.131M |
YoY Change | -54.95% | -40.38% |
TOTAL LIABILITIES | ||
Total Short-Term Liabilities | $15.62M | $13.14M |
Total Long-Term Liabilities | $815.0K | $1.131M |
Total Liabilities | $58.98M | $62.90M |
YoY Change | -11.05% | -10.22% |
SHAREHOLDERS EQUITY | ||
Retained Earnings | -$275.2M | -$264.1M |
YoY Change | 35.77% | 44.4% |
Common Stock | $41.00K | $41.00K |
YoY Change | 2.5% | 2.5% |
Preferred Stock | ||
YoY Change | ||
Treasury Stock (at cost) | ||
YoY Change | ||
Treasury Stock Shares | ||
Shareholders Equity | $360.0K | $10.90M |
YoY Change | ||
Total Liabilities & Shareholders Equity | $59.34M | $73.80M |
YoY Change | -55.39% | -52.74% |
Cashflow Statement
Concept | 2024 Q2 | 2024 Q1 |
---|---|---|
OPERATING ACTIVITIES | ||
Net Income | -$11.16M | -$18.98M |
YoY Change | -43.84% | -22.99% |
Depreciation, Depletion And Amortization | $255.0K | $1.693M |
YoY Change | -64.08% | 138.45% |
Cash From Operating Activities | -$16.12M | -$22.43M |
YoY Change | -13.1% | -12.18% |
INVESTING ACTIVITIES | ||
Capital Expenditures | $106.0K | $17.00K |
YoY Change | -55.83% | -87.41% |
Acquisitions | ||
YoY Change | ||
Other Investing Activities | $0.00 | $0.00 |
YoY Change | -100.0% | -100.0% |
Cash From Investing Activities | -$106.0K | -$17.00K |
YoY Change | -100.3% | -99.53% |
FINANCING ACTIVITIES | ||
Cash Dividend Paid | ||
YoY Change | ||
Common Stock Issuance & Retirement, Net | ||
YoY Change | ||
Debt Paid & Issued, Net | ||
YoY Change | ||
Cash From Financing Activities | 73.00K | $1.352M |
YoY Change | -102.01% | -98.0% |
NET CHANGE | ||
Cash From Operating Activities | -16.12M | -$22.43M |
Cash From Investing Activities | -106.0K | -$17.00K |
Cash From Financing Activities | 73.00K | $1.352M |
Net Change In Cash | -16.15M | -$21.09M |
YoY Change | -218.95% | -154.62% |
FREE CASH FLOW | ||
Cash From Operating Activities | -$16.12M | -$22.43M |
Capital Expenditures | $106.0K | $17.00K |
Free Cash Flow | -$16.23M | -$22.44M |
YoY Change | -13.65% | -12.57% |
Facts In Submission
Frame | Concept Type | Concept / XBRL Key | Value | Unit |
---|---|---|---|---|
CY2023Q1 | us-gaap |
Profit Loss
ProfitLoss
|
-24642000 | usd |
CY2024Q1 | us-gaap |
Deferred Finance Costs Noncurrent Net
DeferredFinanceCostsNoncurrentNet
|
142000 | usd |
CY2023Q4 | us-gaap |
Deferred Finance Costs Noncurrent Net
DeferredFinanceCostsNoncurrentNet
|
146000 | usd |
CY2024Q1 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
17462000 | usd |
CY2023Q1 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
16641000 | usd |
CY2024Q1 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
5445000 | usd |
CY2023Q1 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
9574000 | usd |
CY2024Q1 | us-gaap |
Operating Expenses
OperatingExpenses
|
22907000 | usd |
CY2023Q1 | us-gaap |
Operating Expenses
OperatingExpenses
|
26215000 | usd |
CY2024Q1 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-19510000 | usd |
CY2023Q1 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-22972000 | usd |
CY2024Q1 | us-gaap |
Embedded Derivative Gain Loss On Embedded Derivative Net
EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet
|
0 | usd |
CY2023Q1 | us-gaap |
Embedded Derivative Gain Loss On Embedded Derivative Net
EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet
|
-84000 | usd |
CY2024Q1 | us-gaap |
Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
|
532000 | usd |
CY2023Q1 | us-gaap |
Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
|
-1477000 | usd |
CY2024Q1 | us-gaap |
Income Loss Attributable To Parent
IncomeLossAttributableToParent
|
-18978000 | usd |
CY2023Q1 | us-gaap |
Income Loss Attributable To Parent
IncomeLossAttributableToParent
|
-24533000 | usd |
CY2024Q1 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
0 | usd |
CY2023Q1 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
109000 | usd |
CY2024Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-18978000 | usd |
CY2023Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-24642000 | usd |
CY2024Q1 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-0.46 | |
CY2024Q1 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-0.46 | |
CY2023Q1 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-1.93 | |
CY2023Q1 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-1.93 | |
CY2024Q1 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
40938464 | shares |
CY2024Q1 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
40938464 | shares |
CY2023Q1 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
12783523 | shares |
CY2023Q1 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
12783523 | shares |
CY2024Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-18978000 | usd |
CY2023Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-24642000 | usd |
CY2024Q1 | us-gaap |
Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
|
0 | usd |
CY2023Q1 | us-gaap |
Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
|
177000 | usd |
CY2024Q1 | us-gaap |
Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
|
-18978000 | usd |
CY2023Q1 | us-gaap |
Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
|
-24465000 | usd |
CY2023Q4 | us-gaap |
Temporary Equity Shares Issued
TemporaryEquitySharesIssued
|
0 | shares |
CY2023Q4 | us-gaap |
Temporary Equity Carrying Amount Including Portion Attributable To Noncontrolling Interests
TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests
|
0 | usd |
CY2023Q4 | us-gaap |
Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
26532000 | usd |
CY2024Q1 | us-gaap |
Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
|
2000 | usd |
CY2024Q1 | us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
1057000 | usd |
CY2024Q1 | us-gaap |
Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
|
2282000 | usd |
CY2024Q1 | us-gaap |
Profit Loss
ProfitLoss
|
-18978000 | usd |
CY2024Q1 | us-gaap |
Temporary Equity Shares Issued
TemporaryEquitySharesIssued
|
0 | shares |
CY2024Q1 | us-gaap |
Temporary Equity Carrying Amount Including Portion Attributable To Noncontrolling Interests
TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests
|
0 | usd |
CY2024Q1 | us-gaap |
Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
10895000 | usd |
CY2022Q4 | us-gaap |
Temporary Equity Shares Issued
TemporaryEquitySharesIssued
|
8700885 | shares |
CY2022Q4 | us-gaap |
Temporary Equity Carrying Amount Including Portion Attributable To Noncontrolling Interests
TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests
|
107808000 | usd |
CY2022Q4 | us-gaap |
Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
-142670000 | usd |
CY2023Q1 | us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
265000 | usd |
CY2023Q1 | us-gaap |
Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
|
177000 | usd |
CY2023Q1 | carm |
Stock Issued During Period Values Preclosure Financing Transaction
StockIssuedDuringPeriodValuesPreclosureFinancingTransaction
|
30640000 | usd |
CY2023Q1 | us-gaap |
Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
|
42447000 | usd |
CY2023Q1 | us-gaap |
Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
|
72044000 | usd |
CY2023Q1 | carm |
Reclassifications Of Temporary To Permanent Equity Shares
ReclassificationsOfTemporaryToPermanentEquityShares
|
-8700885 | shares |
CY2023Q1 | us-gaap |
Reclassifications Of Temporary To Permanent Equity
ReclassificationsOfTemporaryToPermanentEquity
|
-107808000 | usd |
CY2023Q1 | carm |
Stock Issued During Period Shares Conversion Of Convertible Preferred Stock And Non Controlling Interests Upon Merger
StockIssuedDuringPeriodSharesConversionOfConvertiblePreferredStockAndNonControllingInterestsUponMerger
|
107809000 | usd |
CY2023Q1 | us-gaap |
Profit Loss
ProfitLoss
|
-24642000 | usd |
CY2023Q1 | us-gaap |
Temporary Equity Shares Issued
TemporaryEquitySharesIssued
|
0 | shares |
CY2023Q1 | us-gaap |
Temporary Equity Carrying Amount Including Portion Attributable To Noncontrolling Interests
TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests
|
0 | usd |
CY2023Q1 | us-gaap |
Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
86070000 | usd |
CY2024Q1 | us-gaap |
Profit Loss
ProfitLoss
|
-18978000 | usd |
CY2024Q1 | us-gaap |
Depreciation And Amortization
DepreciationAndAmortization
|
1693000 | usd |
CY2023Q1 | us-gaap |
Depreciation And Amortization
DepreciationAndAmortization
|
705000 | usd |
CY2024Q1 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
1057000 | usd |
CY2023Q1 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
265000 | usd |
CY2024Q1 | us-gaap |
Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
|
1360000 | usd |
CY2023Q1 | us-gaap |
Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
|
1329000 | usd |
CY2024Q1 | us-gaap |
Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
|
0 | usd |
CY2023Q1 | us-gaap |
Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
|
1283000 | usd |
CY2024Q1 | us-gaap |
Embedded Derivative Gain Loss On Embedded Derivative Net
EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet
|
0 | usd |
CY2023Q1 | us-gaap |
Embedded Derivative Gain Loss On Embedded Derivative Net
EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet
|
-84000 | usd |
CY2024Q1 | carm |
Accretion On Marketable Securities
AccretionOnMarketableSecurities
|
0 | usd |
CY2023Q1 | carm |
Accretion On Marketable Securities
AccretionOnMarketableSecurities
|
163000 | usd |
CY2024Q1 | carm |
Write Off Of Property And Equipment
WriteOffOfPropertyAndEquipment
|
67000 | usd |
CY2023Q1 | carm |
Write Off Of Property And Equipment
WriteOffOfPropertyAndEquipment
|
0 | usd |
CY2024Q1 | carm |
Noncash Interest Expense
NoncashInterestExpense
|
236000 | usd |
CY2023Q1 | carm |
Noncash Interest Expense
NoncashInterestExpense
|
41000 | usd |
CY2024Q1 | us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
1572000 | usd |
CY2023Q1 | us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
1623000 | usd |
CY2024Q1 | us-gaap |
Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
|
-1826000 | usd |
CY2023Q1 | us-gaap |
Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
|
2823000 | usd |
CY2024Q1 | us-gaap |
Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
|
-2933000 | usd |
CY2023Q1 | us-gaap |
Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
|
-4445000 | usd |
CY2024Q1 | us-gaap |
Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
|
-224000 | usd |
CY2023Q1 | us-gaap |
Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
|
-323000 | usd |
CY2024Q1 | us-gaap |
Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
|
-1355000 | usd |
CY2023Q1 | us-gaap |
Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
|
-868000 | usd |
CY2024Q1 | us-gaap |
Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
|
50000 | usd |
CY2023Q1 | us-gaap |
Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
|
0 | usd |
CY2024Q1 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-22425000 | usd |
CY2023Q1 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-25534000 | usd |
CY2024Q1 | us-gaap |
Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
|
0 | usd |
CY2023Q1 | us-gaap |
Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
|
34460000 | usd |
CY2024Q1 | carm |
Payments For Proceeds From Marketable Securities
PaymentsForProceedsFromMarketableSecurities
|
0 | usd |
CY2023Q1 | carm |
Payments For Proceeds From Marketable Securities
PaymentsForProceedsFromMarketableSecurities
|
-31000000 | usd |
CY2024Q1 | us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
17000 | usd |
CY2023Q1 | us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
135000 | usd |
CY2024Q1 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-17000 | usd |
CY2023Q1 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-3595000 | usd |
CY2024Q1 | carm |
Cash Cash Equivalents And Restricted Cash Acquired In Reverse Recapitalization Financing Activities
CashCashEquivalentsAndRestrictedCashAcquiredInReverseRecapitalizationFinancingActivities
|
0 | usd |
CY2023Q1 | carm |
Cash Cash Equivalents And Restricted Cash Acquired In Reverse Recapitalization Financing Activities
CashCashEquivalentsAndRestrictedCashAcquiredInReverseRecapitalizationFinancingActivities
|
37903000 | usd |
CY2024Q1 | carm |
Payment Of Finance Costs Reverse Recapitalization Financing Activities
PaymentOfFinanceCostsReverseRecapitalizationFinancingActivities
|
0 | usd |
CY2023Q1 | carm |
Payment Of Finance Costs Reverse Recapitalization Financing Activities
PaymentOfFinanceCostsReverseRecapitalizationFinancingActivities
|
1742000 | usd |
CY2024Q1 | carm |
Proceeds From Issuance Of Common Stock Pre Closing Financing
ProceedsFromIssuanceOfCommonStockPreClosingFinancing
|
0 | usd |
CY2023Q1 | carm |
Proceeds From Issuance Of Common Stock Pre Closing Financing
ProceedsFromIssuanceOfCommonStockPreClosingFinancing
|
30640000 | usd |
CY2024Q1 | us-gaap |
Finance Lease Principal Payments
FinanceLeasePrincipalPayments
|
1319000 | usd |
CY2023Q1 | us-gaap |
Finance Lease Principal Payments
FinanceLeasePrincipalPayments
|
106000 | usd |
CY2024Q1 | carm |
Proceeds From Failed Sale Leaseback Transaction
ProceedsFromFailedSaleLeasebackTransaction
|
686000 | usd |
CY2023Q1 | carm |
Proceeds From Failed Sale Leaseback Transaction
ProceedsFromFailedSaleLeasebackTransaction
|
1092000 | usd |
CY2024Q1 | carm |
Payment Of Finance Liability Failed Sale Leaseback Transaction
PaymentOfFinanceLiabilityFailedSaleLeasebackTransaction
|
303000 | usd |
CY2023Q1 | carm |
Payment Of Finance Liability Failed Sale Leaseback Transaction
PaymentOfFinanceLiabilityFailedSaleLeasebackTransaction
|
45000 | usd |
CY2024Q1 | us-gaap |
Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
|
2000 | usd |
CY2023Q1 | us-gaap |
Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
|
0 | usd |
CY2024Q1 | us-gaap |
Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
|
2286000 | usd |
CY2023Q1 | us-gaap |
Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
|
0 | usd |
CY2024Q1 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
1352000 | usd |
CY2023Q1 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
67742000 | usd |
CY2024Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
|
-21090000 | usd |
CY2023Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
|
38613000 | usd |
CY2023Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
77605000 | usd |
CY2022Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
24194000 | usd |
CY2024Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
56515000 | usd |
CY2023Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
62807000 | usd |
CY2024Q1 | us-gaap |
Interest Paid Net
InterestPaidNet
|
50000 | usd |
CY2023Q1 | us-gaap |
Interest Paid Net
InterestPaidNet
|
45000 | usd |
CY2024Q1 | carm |
Noncash Or Part Noncash Acquisition Equity Assumed
NoncashOrPartNoncashAcquisitionEquityAssumed
|
0 | usd |
CY2023Q1 | carm |
Noncash Or Part Noncash Acquisition Equity Assumed
NoncashOrPartNoncashAcquisitionEquityAssumed
|
122204000 | usd |
CY2024Q1 | us-gaap |
Notes Reduction
NotesReduction
|
0 | usd |
CY2023Q1 | us-gaap |
Notes Reduction
NotesReduction
|
42447000 | usd |
CY2024Q1 | carm |
Noncash Or Part Noncash Reverse Recapitalization Costs In Accrued Expenses
NoncashOrPartNoncashReverseRecapitalizationCostsInAccruedExpenses
|
0 | usd |
CY2023Q1 | carm |
Noncash Or Part Noncash Reverse Recapitalization Costs In Accrued Expenses
NoncashOrPartNoncashReverseRecapitalizationCostsInAccruedExpenses
|
4071000 | usd |
CY2024Q1 | carm |
Noncash Or Part Noncash Unrealized Gain Loss On Marketable Securities
NoncashOrPartNoncashUnrealizedGainLossOnMarketableSecurities
|
0 | usd |
CY2023Q1 | us-gaap |
Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Assets Prepaid Expense And Other Assets
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets
|
1316000 | usd |
CY2023Q1 | carm |
Businesscombinationrecognizedidentifiableassetsacquiredrestrictedcash
Businesscombinationrecognizedidentifiableassetsacquiredrestrictedcash
|
30000 | usd |
CY2023Q1 | us-gaap |
Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Liabilities
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities
|
3499000 | usd |
CY2023Q1 | carm |
Noncash Or Part Noncash Unrealized Gain Loss On Marketable Securities
NoncashOrPartNoncashUnrealizedGainLossOnMarketableSecurities
|
177000 | usd |
CY2024Q1 | us-gaap |
Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
|
4337000 | usd |
CY2023Q1 | us-gaap |
Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
|
0 | usd |
CY2024Q1 | us-gaap |
Right Of Use Asset Obtained In Exchange For Finance Lease Liability
RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability
|
2470000 | usd |
CY2023Q1 | us-gaap |
Right Of Use Asset Obtained In Exchange For Finance Lease Liability
RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability
|
0 | usd |
CY2024Q1 | us-gaap |
Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
|
59000 | usd |
CY2023Q1 | us-gaap |
Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
|
49000 | usd |
CY2024Q1 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-264100000 | usd |
CY2024Q1 | us-gaap |
Cash Cash Equivalents And Short Term Investments
CashCashEquivalentsAndShortTermInvestments
|
56500000 | usd |
CY2024Q1 | us-gaap |
Use Of Estimates
UseOfEstimates
|
<div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of unaudited interim consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the unaudited interim consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from such estimates. Estimates and assumptions are periodically reviewed, and the effects of revisions are reflected in the unaudited interim consolidated financial statements in the period they are determined to be necessary.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Significant areas that require management’s estimates include the stock-based compensation assumptions, the estimated useful lives of property and equipment, and accrued research and development expenses.</span></div> | |
CY2023Q1 | us-gaap |
Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Cash And Equivalents
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents
|
37873000 | usd |
CY2024Q1 | us-gaap |
Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
|
<div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Concentration of credit risk</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial instruments that potentially subject the Company to significant concentrations of credit risk consist primarily of cash and cash equivalents. The Company maintains deposits in federally insured financial institutions in excess of federally insured limits. The Company has not experienced any losses in such accounts and believes it is not exposed to significant risk on its cash and cash equivalents.</span></div> | |
CY2024Q1 | us-gaap |
Number Of Operating Segments
NumberOfOperatingSegments
|
1 | segment |
CY2023Q1 | us-gaap |
Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Assets Marketable Securities
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsMarketableSecurities
|
44588000 | usd |
CY2023Q1 | us-gaap |
Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Assets
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets
|
80308000 | usd |
CY2023Q1 | us-gaap |
Business Acquisition Cost Of Acquired Entity Transaction Costs
BusinessAcquisitionCostOfAcquiredEntityTransactionCosts
|
8264000 | usd |
CY2023Q1 | us-gaap |
Business Combination Recognized Identifiable Assets Acquired Goodwill And Liabilities Assumed Net
BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet
|
72044000 | usd |
CY2024Q1 | carm |
Prepaid Research And Development Current
PrepaidResearchAndDevelopmentCurrent
|
1232000 | usd |
CY2023Q4 | carm |
Prepaid Research And Development Current
PrepaidResearchAndDevelopmentCurrent
|
278000 | usd |
CY2024Q1 | us-gaap |
Prepaid Insurance
PrepaidInsurance
|
887000 | usd |
CY2023Q4 | us-gaap |
Prepaid Insurance
PrepaidInsurance
|
402000 | usd |
CY2024Q1 | us-gaap |
Deposits Assets Current
DepositsAssetsCurrent
|
1548000 | usd |
CY2023Q4 | us-gaap |
Deposits Assets Current
DepositsAssetsCurrent
|
891000 | usd |
CY2024Q1 | us-gaap |
Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
|
771000 | usd |
CY2023Q4 | us-gaap |
Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
|
1295000 | usd |
CY2024Q1 | us-gaap |
Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
|
4438000 | usd |
CY2023Q4 | us-gaap |
Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
|
2866000 | usd |
CY2024Q1 | carm |
Accrued Research And Development Expense Current
AccruedResearchAndDevelopmentExpenseCurrent
|
3165000 | usd |
CY2023Q4 | carm |
Accrued Research And Development Expense Current
AccruedResearchAndDevelopmentExpenseCurrent
|
3131000 | usd |
CY2024Q1 | us-gaap |
Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
|
669000 | usd |
CY2023Q4 | us-gaap |
Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
|
1366000 | usd |
CY2024Q1 | us-gaap |
Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
|
881000 | usd |
CY2023Q4 | us-gaap |
Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
|
3100000 | usd |
CY2024Q1 | us-gaap |
Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
|
14000 | usd |
CY2023Q4 | us-gaap |
Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
|
65000 | usd |
CY2024Q1 | us-gaap |
Accrued Liabilities Current
AccruedLiabilitiesCurrent
|
4729000 | usd |
CY2023Q4 | us-gaap |
Accrued Liabilities Current
AccruedLiabilitiesCurrent
|
7662000 | usd |
CY2024Q1 | us-gaap |
Operating Lease Cost
OperatingLeaseCost
|
1469000 | usd |
CY2023Q1 | us-gaap |
Operating Lease Cost
OperatingLeaseCost
|
1433000 | usd |
CY2024Q1 | us-gaap |
Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
|
1298000 | usd |
CY2023Q1 | us-gaap |
Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
|
297000 | usd |
CY2024Q1 | us-gaap |
Finance Lease Interest Expense
FinanceLeaseInterestExpense
|
236000 | usd |
CY2023Q1 | us-gaap |
Finance Lease Interest Expense
FinanceLeaseInterestExpense
|
45000 | usd |
CY2024Q1 | carm |
Finance Lease Cost
FinanceLeaseCost
|
1534000 | usd |
CY2023Q1 | carm |
Finance Lease Cost
FinanceLeaseCost
|
342000 | usd |
CY2024Q1 | us-gaap |
Variable Lease Cost
VariableLeaseCost
|
472000 | usd |
CY2023Q1 | us-gaap |
Variable Lease Cost
VariableLeaseCost
|
750000 | usd |
CY2024Q1 | us-gaap |
Lease Cost
LeaseCost
|
3475000 | usd |
CY2023Q1 | us-gaap |
Lease Cost
LeaseCost
|
2525000 | usd |
CY2024Q1 | us-gaap |
Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
|
P2Y3M18D | |
CY2023Q1 | us-gaap |
Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
|
P2Y2M12D | |
CY2024Q1 | us-gaap |
Finance Lease Weighted Average Remaining Lease Term1
FinanceLeaseWeightedAverageRemainingLeaseTerm1
|
P1Y6M | |
CY2023Q1 | us-gaap |
Finance Lease Weighted Average Remaining Lease Term1
FinanceLeaseWeightedAverageRemainingLeaseTerm1
|
P1Y10M24D | |
CY2024Q1 | us-gaap |
Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
|
0.093 | |
CY2023Q1 | us-gaap |
Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
|
0.095 | |
CY2024Q1 | us-gaap |
Finance Lease Weighted Average Discount Rate Percent
FinanceLeaseWeightedAverageDiscountRatePercent
|
0.090 | |
CY2023Q1 | us-gaap |
Finance Lease Weighted Average Discount Rate Percent
FinanceLeaseWeightedAverageDiscountRatePercent
|
0.090 | |
CY2024Q1 | us-gaap |
Operating Lease Payments
OperatingLeasePayments
|
1463000 | usd |
CY2023Q1 | us-gaap |
Operating Lease Payments
OperatingLeasePayments
|
1448000 | usd |
CY2024Q1 | us-gaap |
Finance Lease Interest Payment On Liability
FinanceLeaseInterestPaymentOnLiability
|
236000 | usd |
CY2023Q1 | us-gaap |
Finance Lease Interest Payment On Liability
FinanceLeaseInterestPaymentOnLiability
|
45000 | usd |
CY2024Q1 | carm |
Financing Cash Used In Finance Leases
FinancingCashUsedInFinanceLeases
|
1319000 | usd |
CY2023Q1 | carm |
Financing Cash Used In Finance Leases
FinancingCashUsedInFinanceLeases
|
106000 | usd |
CY2024Q1 | us-gaap |
Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
|
2195000 | usd |
CY2024Q1 | us-gaap |
Finance Lease Liability Payments Remainder Of Fiscal Year
FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear
|
1153000 | usd |
CY2024Q1 | us-gaap |
Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
|
2628000 | usd |
CY2024Q1 | us-gaap |
Finance Lease Liability Payments Due Next Twelve Months
FinanceLeaseLiabilityPaymentsDueNextTwelveMonths
|
1261000 | usd |
CY2024Q1 | us-gaap |
Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
|
427000 | usd |
CY2024Q1 | us-gaap |
Finance Lease Liability Payments Due Year Two
FinanceLeaseLiabilityPaymentsDueYearTwo
|
20000 | usd |
CY2024Q1 | us-gaap |
Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
|
232000 | usd |
CY2024Q1 | us-gaap |
Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
|
240000 | usd |
CY2024Q1 | carm |
Lessee Operating Lease Liability To Be Paid After Year Four
LesseeOperatingLeaseLiabilityToBePaidAfterYearFour
|
184000 | usd |
CY2024Q1 | us-gaap |
Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
|
5906000 | usd |
CY2024Q1 | us-gaap |
Finance Lease Liability Payments Due
FinanceLeaseLiabilityPaymentsDue
|
2434000 | usd |
CY2024Q1 | us-gaap |
Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
|
673000 | usd |
CY2024Q1 | us-gaap |
Finance Lease Liability Undiscounted Excess Amount
FinanceLeaseLiabilityUndiscountedExcessAmount
|
175000 | usd |
CY2024Q1 | us-gaap |
Operating Lease Liability
OperatingLeaseLiability
|
5233000 | usd |
CY2024Q1 | us-gaap |
Finance Lease Liability
FinanceLeaseLiability
|
2259000 | usd |
CY2023Q1 | us-gaap |
Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
|
3730608 | shares |
CY2023Q1 | us-gaap |
Shares Issued Price Per Share
SharesIssuedPricePerShare
|
8.21 | |
CY2023Q1 | us-gaap |
Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
|
30600000 | usd |
CY2023Q1 | us-gaap |
Stock Issued During Period Shares Conversion Of Convertible Securities
StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
|
5059338 | shares |
CY2023Q1 | us-gaap |
Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
|
35000000 | usd |
CY2023Q1 | carm |
Stock Issued During Period Shares Conversion Of Convertible Preferred Stock And Non Controlling Interests
StockIssuedDuringPeriodSharesConversionOfConvertiblePreferredStockAndNonControllingInterests
|
18872711 | shares |
CY2023Q1 | us-gaap |
Stock Issued During Period Shares Acquisitions
StockIssuedDuringPeriodSharesAcquisitions
|
10374272 | shares |
CY2023Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
6023370 | shares |
CY2023Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
|
3.94 | |
CY2024Q1 | us-gaap |
Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
|
1579 | shares |
CY2024Q1 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
|
1.42 | |
CY2024Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
|
2000 | usd |
CY2024Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
|
2226000 | shares |
CY2024Q1 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
|
2.10 | |
CY2024Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
|
37244 | shares |
CY2024Q1 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
|
5.58 | |
CY2024Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
8210547 | shares |
CY2024Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
|
3.43 | |
CY2024Q1 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
|
P8Y2M12D | |
CY2024Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
|
4241000 | usd |
CY2024Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
|
2737710 | shares |
CY2024Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
|
1.24 | |
CY2024Q1 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
|
P6Y | |
CY2024Q1 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
|
3443000 | usd |
CY2024Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber
|
8210547 | shares |
CY2024Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice
|
3.43 | |
CY2024Q1 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1
|
P8Y2M12D | |
CY2024Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue
|
4241000 | usd |
CY2024Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
|
1.72 | |
CY2023Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
|
2.64 | |
CY2024Q1 | us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
1057000 | usd |
CY2023Q1 | us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
265000 | usd |
CY2024Q1 | us-gaap |
Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
|
13900000 | usd |
CY2024Q1 | us-gaap |
Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
|
P3Y2M12D | |
CY2024Q1 | us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
3400000 | usd |
CY2023Q1 | us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
3200000 | usd |
CY2024Q1 | carm |
Revenue Remaining Performance Obligation Research And Development Amount
RevenueRemainingPerformanceObligationResearchAndDevelopmentAmount
|
45786000 | usd |
CY2024Q1 | carm |
Revenue Remaining Performance Obligation Option Rights Amount
RevenueRemainingPerformanceObligationOptionRightsAmount
|
45000000 | usd |
CY2024Q1 | us-gaap |
Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
|
90786000 | usd |
CY2023Q4 | us-gaap |
Contract With Customer Liability
ContractWithCustomerLiability
|
46413000 | usd |
CY2022Q4 | us-gaap |
Contract With Customer Liability
ContractWithCustomerLiability
|
47459000 | usd |
CY2024Q1 | carm |
Contract With Customer Liability Deferral Of Revenue
ContractWithCustomerLiabilityDeferralOfRevenue
|
3173000 | usd |
CY2023Q1 | carm |
Contract With Customer Liability Deferral Of Revenue
ContractWithCustomerLiabilityDeferralOfRevenue
|
2920000 | usd |
CY2024Q1 | us-gaap |
Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
|
-3397000 | usd |
CY2023Q1 | us-gaap |
Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
|
-3243000 | usd |
CY2024Q1 | us-gaap |
Contract With Customer Liability
ContractWithCustomerLiability
|
46189000 | usd |
CY2023Q1 | us-gaap |
Contract With Customer Liability
ContractWithCustomerLiability
|
47136000 | usd |
CY2024Q1 | ecd |
Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
|
false | |
CY2024Q1 | ecd |
Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
|
false | |
CY2024Q1 | ecd |
Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
|
false | |
CY2024Q1 | ecd |
Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
|
false |